These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1257 related items for PubMed ID: 17954710
1. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Cancer Care Ontario, American Society of Clinical Oncology. J Clin Oncol; 2007 Dec 01; 25(34):5506-18. PubMed ID: 17954710 [Abstract] [Full Text] [Related]
2. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association. Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766 [Abstract] [Full Text] [Related]
3. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer. Johnson BE, Rabin MS. Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607 [Abstract] [Full Text] [Related]
4. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease. Wakelee H, Dubey S, Gandara D. Oncologist; 2007 Mar 01; 12(3):331-7. PubMed ID: 17405898 [Abstract] [Full Text] [Related]
5. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK. Cancer Prev Control; 1997 Dec 01; 1(5):366-78. PubMed ID: 9765759 [Abstract] [Full Text] [Related]
6. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer]. Barlési F. Rev Mal Respir; 2006 Nov 01; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336 [Abstract] [Full Text] [Related]
10. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer. Bernstein ED, Herbert SM, Hanna NH. Ann Surg Oncol; 2006 Mar 01; 13(3):291-301. PubMed ID: 16450219 [Abstract] [Full Text] [Related]
11. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G, European Organisation for Research and Treatment of Cancer-Lung Cancer Group. J Natl Cancer Inst; 2007 Mar 21; 99(6):442-50. PubMed ID: 17374834 [Abstract] [Full Text] [Related]
12. Clinical issues in the management of non-small-cell lung cancer and the role of platinum-based therapy. Socinski MA. Clin Lung Cancer; 2004 Mar 21; 5(5):274-89. PubMed ID: 15086966 [Abstract] [Full Text] [Related]
13. Adjuvant chemotherapy and radiotherapy in non-small cell lung cancer. Erman M, Moretti L, Soria JC, Le Chevalier T, Van Houtte P. Semin Radiat Oncol; 2004 Oct 21; 14(4):315-21. PubMed ID: 15558506 [Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial. Dunant A, Pignon JP, Le Chevalier T. Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606 [Abstract] [Full Text] [Related]
15. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Okawara G, Rusthoven J, Newman T, Findlay B, Evans W. Cancer Prev Control; 1997 Aug 01; 1(3):249-59. PubMed ID: 9765750 [Abstract] [Full Text] [Related]
16. [Current status of the neo-adjuvant and adjuvant therapy for the resectable non-small cell lung cancer]. Yamaguchi M, Fukuyama Y, Ichinose Y. Gan To Kagaku Ryoho; 2003 Feb 01; 30(2):203-8. PubMed ID: 12610867 [Abstract] [Full Text] [Related]
17. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). Tsuchiya R, Suzuki K, Ichinose Y, Watanabe Y, Yasumitsu T, Ishizuka N, Kato H. J Thorac Cardiovasc Surg; 2005 May 01; 129(5):977-83. PubMed ID: 15867769 [Abstract] [Full Text] [Related]
18. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)]. Nakajima E, Katou H. Kyobu Geka; 2008 Jan 01; 61(1):4-8. PubMed ID: 18186265 [Abstract] [Full Text] [Related]
19. Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial. de Boer RH, Smith IE, Pastorino U, O'Brien ME, Ramage F, Ashley S, Goldstraw P. Br J Cancer; 1999 Mar 01; 79(9-10):1514-8. PubMed ID: 10188899 [Abstract] [Full Text] [Related]
20. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group. Lung Cancer; 2005 Jun 01; 48(3):389-97. PubMed ID: 15893008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]